Does ATEZOLIZUMAB Cause Cholangitis? 145 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 145 reports of Cholangitis have been filed in association with ATEZOLIZUMAB (Tecentriq Hybreza). This represents 0.4% of all adverse event reports for ATEZOLIZUMAB.
145
Reports of Cholangitis with ATEZOLIZUMAB
0.4%
of all ATEZOLIZUMAB reports
27
Deaths
80
Hospitalizations
How Dangerous Is Cholangitis From ATEZOLIZUMAB?
Of the 145 reports, 27 (18.6%) resulted in death, 80 (55.2%) required hospitalization, and 7 (4.8%) were considered life-threatening.
Is Cholangitis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ATEZOLIZUMAB. However, 145 reports have been filed with the FAERS database.
What Other Side Effects Does ATEZOLIZUMAB Cause?
Death (3,591)
Off label use (2,340)
Disease progression (1,828)
Pyrexia (1,599)
Diarrhoea (1,490)
Fatigue (1,253)
Anaemia (1,195)
Pneumonia (1,036)
Nausea (953)
Dyspnoea (938)
What Other Drugs Cause Cholangitis?
NIVOLUMAB (389)
PEMBROLIZUMAB (357)
PACLITAXEL (289)
GEMCITABINE (225)
TACROLIMUS (213)
BEVACIZUMAB (176)
FLUOROURACIL (175)
DURVALUMAB (157)
OXALIPLATIN (147)
IRINOTECAN (146)
Which ATEZOLIZUMAB Alternatives Have Lower Cholangitis Risk?
ATEZOLIZUMAB vs ATLANTIC SALMON OIL
ATEZOLIZUMAB vs ATOGEPANT
ATEZOLIZUMAB vs ATOMOXETINE
ATEZOLIZUMAB vs ATOMOXETINE\ATOMOXETINE
ATEZOLIZUMAB vs ATORVASTATIN